230170085	230170085	CD	B-NP	O
|	|	NN	I-NP	O
SMO	SMO	NN	I-NP	O
|	|	NN	I-NP	O
94184553	94184553	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7752368	7752368	CD	B-NP	O
|	|	CC	I-NP	O
6/17/2006	6/17/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
polymyositis	polymyositis	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/2006	11/19/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/14/2006	5/14/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
BURKEL	BURKEL	NN	B-NP	O
,	,	,	O	O
VINCENZO	VINCENZO	NN	B-NP	O
955-98-31-0	955-98-31-0	CD	I-NP	O
Teette	Teette	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/17/06	5/17/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
AYOTTE	AYOTTE	NNP	B-NP	O
,	,	,	O	O
CALVIN	CALVIN	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
TIAZAC	TIAZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
RIPPEE	RIPPEE	NNP	B-NP	O
,	,	,	O	O
ELDON	ELDON	NNP	B-NP	O
E	E	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LABETALOL	LABETALOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COLACE	COLACE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FOLATE	FOLATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FOLIC	FOLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
IMDUR	IMDUR	NN	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
90	90	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
LABETALOL	LABETALOL	NN	I-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
GERRIOR	GERRIOR	NNP	B-NP	O
,	,	,	O	O
ARMAND	ARMAND	NNP	B-NP	O
M	M	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TIAZAC	TIAZAC	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
981777537	981777537	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LABETALOL	LABETALOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
SENECAL	SENECAL	NNP	B-NP	O
,	,	,	O	O
CORNELIUS	CORNELIUS	NNP	B-NP	O
S	S	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
992342018	992342018	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LABETALOL	LABETALOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
WILL	WILL	MD	B-VP	O
MONITOR	MONITOR	VB	I-VP	O
ATIVAN	ATIVAN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.5-1	0.5-1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
MEDROL	MEDROL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METHYLPREDNISOLONE	METHYLPREDNISOLONE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
24	24	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
NITROGLYCERIN	NITROGLYCERIN	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	O
0.4	0.4	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-DNA
SL	SL	NN	I-NP	I-DNA
Q5MIN	Q5MIN	NN	I-NP	I-DNA
X	X	NN	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	B-protein
Chest	Chest	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
THIAMINE	THIAMINE	NNP	I-NP	I-protein
HCL	HCL	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
BACTRIM	BACTRIM	NN	I-NP	I-protein
DS	DS	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NN	I-NP	I-protein
DOU	DOU	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/11	10/11	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
QMonday	QMonday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Eldridge	Eldridge	NNP	I-NP	O
Gautreau	Gautreau	NNP	I-NP	O
in	in	IN	B-PP	O
rheumatology	rheumatology	NN	B-NP	O
6/16/06	6/16/06	CD	I-NP	O
at	at	IN	B-PP	O
11AM	11AM	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Dino	Dino	NNP	I-NP	O
Mesdaq	Mesdaq	NNP	I-NP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
11/7/06	11/7/06	CD	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Donte	Donte	NNP	I-NP	O
Arcuri	Arcuri	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
new	new	JJ	I-NP	O
PCP	PCP	NN	I-NP	O
1/18/06	1/18/06	CD	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
polymyositis	polymyositis	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
valvular	valvular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
polysubstance	polysubstance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
-	-	HYPH	B-NP	O
cocaine/alcohol	cocaine/alcohol	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Mr	Mr	NNP	B-NP	O
Bickford	Bickford	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
cocaine/EtOH	cocaine/EtOH	NN	B-NP	O
abuse	abuse	NN	I-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
AI/MR	AI/MR	NN	B-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
9	9	CD	B-NP	O
day	day	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
occurring	occur	VBG	B-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
originally	originally	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
with	with	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
polymyositis	polymyositis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CK	CK	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
33	33	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADVP	O
during	during	IN	B-PP	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IVF	IVF	NN	B-NP	B-protein
+	+	SYM	B-VP	O
bicarb	bicarb	NN	B-NP	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
protection	protection	NN	I-NP	O
from	from	IN	B-PP	O
myoglobinuria	myoglobinuria	NN	B-NP	O
and	and	CC	O	O
became	become	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
successful	successful	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
to	to	TO	B-PP	O
euvolemia	euvolemia	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
occurring	occur	VBG	B-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
nonradiating	nonradiating	JJ	B-ADJP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
chest	chest	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
persistently	persistently	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
CP	CP	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
myocarditis	myocarditis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
,	,	,	O	O
CCB	CCB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
ativan	ativan	NN	B-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
solumedrol	solumedrol	NN	I-NP	O
with	with	IN	B-PP	O
immediate	immediate	JJ	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
CK	CK	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-ADVP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
0.64	0.64	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
12	12	CD	I-NP	O
hour	hour	NN	I-NP	O
stay	stay	NN	I-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
CP	CP	NN	B-NP	B-DNA
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
occurring	occur	VBG	B-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
TH	TH	NN	B-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
cocaine	cocaine	NN	B-NP	O
,	,	,	O	O
EtOH	EtOH	NN	B-NP	B-protein
abuse	abuse	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
ativan	ativan	NN	I-NP	I-protein
taper	taper	NN	I-NP	I-protein
last	last	JJ	B-NP	I-protein
admission	admission	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
colonic	colonic	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
adenoma	adenoma	NN	I-NP	O
,	,	,	O	O
MS	MS	NN	B-NP	O
,	,	,	O	O
AI	AI	NNP	B-NP	O
****	****	NNP	I-NP	O
Pre-admission	Pre-admission	NNP	I-NP	O
Medication	Medication	NNP	I-NP	O
List	List	NNP	I-NP	O
for	for	IN	B-PP	O
BIANCUZZO	BIANCUZZO	NNP	B-NP	O
,	,	,	O	O
WAYNE	WAYNE	NNP	B-NP	O
94184553	94184553	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TSMC	TSMC	NN	I-NP	O
-RRB-	-RRB-	IN	B-PP	O
66	66	CD	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ALENDRONATE	ALENDRONATE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOSAMAX	FOSAMAX	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
70	70	CD	I-NP	O
MG	MG	NN	I-NP	O
QWEEK	QWEEK	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	B-protein
water	water	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	B-protein
CARBONATE	CARBONATE	NN	I-NP	I-protein
1500	1500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
600	600	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
ELEM	ELEM	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
/	/	SYM	B-VP	O
VIT	VIT	NN	B-NP	O
D	D	NN	I-NP	O
200	200	CD	B-NP	O
IU	IU	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

DILTIAZEM	DILTIAZEM	NN	B-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TIAZAC	TIAZAC	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
COLACE	COLACE	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

FOLIC	FOLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLATE	FOLATE	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

LABETALOL	LABETALOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
PO	PO	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NN	I-NP	O
BID	BID	NN	I-NP	O
Hold	Hold	NN	I-NP	O
if	if	IN	B-SBAR	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	B-NP	I-protein
60	60	CD	I-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Take	Take	NN	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

LORAZEPAM	LORAZEPAM	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
0.5-1	0.5-1	CD	I-NP	O
MG	MG	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
prn	prn	NN	I-NP	O
:	:	:	O	O
Anxiety	Anxiety	NN	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	O
PO	PO	NN	I-NP	O
60	60	CD	B-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NNP	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

THERAPEUTIC	THERAPEUTIC	NN	B-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
QD	QD	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

THIAMINE	THIAMINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
PO	PO	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NN	B-NP	O
DOUBLE	DOUBLE	NN	I-NP	O
STRENGTH	STRENGTH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BACTRIM	BACTRIM	NN	I-NP	O
DS	DS	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
QD	QD	NN	I-NP	O
***	***	SYM	B-NP	O
PATIENT	PATIENT	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Afeb	Afeb	NN	B-NP	O
,	,	,	O	O
72	72	CD	B-NP	O
,	,	,	I-NP	O
118/52	118/52	CD	I-NP	O
,	,	,	I-NP	O
18	18	CD	I-NP	O
,	,	,	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
glass	glass	NN	B-NP	O
eye	eye	NN	I-NP	O
on	on	IN	B-PP	O
left	left	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	O
III/VI	III/VI	NN	I-NP	O
SEM	SEM	NN	I-NP	O
rad	rad	NN	I-NP	O
to	to	TO	B-PP	O
carotids	carotid	NNS	B-NP	O
,	,	,	O	O
IV/VI	IV/VI	NN	B-NP	O
SM	SM	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
II/VI	II/VI	NN	B-NP	O
DM	DM	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
inaudible	inaudible	JJ	B-NP	O
S2	S2	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
groin	groin	NN	I-NP	O
site	site	NN	I-NP	O
C/D/I	C/D/I	NN	I-NP	O
no	no	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
or	or	CC	O	O
pulsatile	pulsatile	JJ	B-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
scars	scar	NNS	I-NP	O
on	on	IN	B-PP	O
body	body	NN	B-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
:	:	:	O	O
7/13/06	7/13/06	CD	B-NP	O
:	:	:	O	O
ECHO	ECHO	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
EF	EF	NN	I-NP	O
70-75	70-75	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
rheumatic	rheumatic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
MR	MR	NN	B-NP	B-protein
,	,	,	O	O
AS	AS	NN	B-NP	O
,	,	,	O	O
AI	AI	NN	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
PR	PR	NN	B-NP	B-protein
.	.	.	O	O

6/15/06	6/15/06	CD	B-NP	O
:	:	:	O	O
Biopsy	Biopsy	NN	B-NP	O
-	-	HYPH	O	O
vasculitis	vasculitis	NN	B-NP	O
,	,	,	O	O
necrosis	necrosis	NN	B-NP	O
6/15/06	6/15/06	CD	I-NP	O
:	:	:	O	O
CT	CT	NN	B-NP	O
head	head	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
,	,	,	O	O
abd/pel	abd/pel	NN	B-NP	O
:	:	:	O	O
pleural	pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
abd	abd	NN	I-NP	O
process	process	NN	I-NP	O
9/17/06	9/17/06	CD	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

11/7/06	11/7/06	CD	B-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
-	-	HYPH	B-NP	O
nonobstructive	nonobstructive	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	B-protein
6/16	6/16	CD	I-NP	I-protein
KUB	KUB	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
free	free	JJ	I-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
bowel	bowel	NN	I-NP	O
gas	gas	NN	I-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
b/l	b/l	NN	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
retrocardiac	retrocardiac	JJ	B-NP	O
air	air	NN	I-NP	O
bronchograms	bronchogram	NNS	I-NP	O
-	-	:	O	O
likely	likely	JJ	B-ADJP	O
just	just	RB	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
but	but	CC	O	O
ca	ca	MD	B-VP	O
n't	n't	RB	I-VP	O
r/o	r/o	VB	I-VP	O
pna	pna	NN	B-NP	O
.	.	.	O	O

10/27	10/27	CD	B-NP	O
PE	PE	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
Small	Small	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
re-admitted	re-admitted	JJ	B-ADJP	O
for	for	IN	B-PP	O
nocturnal	nocturnal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
anatomy	anatomy	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
CK-MB	CK-MB	NN	I-NP	B-protein
and	and	CC	I-NP	O
troponin	troponin	NN	I-NP	O
were	be	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
from	from	IN	B-PP	O
myocarditis	myocarditis	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
suspected	suspect	VBN	B-VP	O
.	.	.	O	O

Notably	Notably	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	B-DNA
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
often	often	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
pleural	pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
volume	volume	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
intended	intend	VBN	B-VP	O
to	to	TO	I-VP	O
protect	protect	VB	I-VP	O
his	his	PRP$	B-NP	O
kidneys	kidney	NNS	I-NP	O
from	from	IN	B-PP	O
myoglobin	myoglobin	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
diuresing	diurese	VBG	I-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
might	might	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
PND	PND	NN	B-NP	B-protein
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
valvular	valvular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
vasoldilatory	vasoldilatory	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
evening	evening	NN	B-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
increased	increase	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
kept	keep	VBD	B-VP	O
elevated	elevated	JJ	B-ADJP	O
at	at	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
thirty	thirty	CD	I-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
indicated	indicate	VBD	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
RUQ	RUQ	NN	I-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	O
protocol	protocol	NN	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
responded	respond	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
to	to	TO	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
further	further	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
again	again	RB	B-ADJP	O
responsive	responsive	JJ	I-ADJP	O
to	to	TO	B-PP	O
lasix	lasix	NN	B-NP	O
and	and	CC	I-NP	O
position	position	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
valvular	valvular	JJ	I-NP	O
disease	disease	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
equivalent	equivalent	JJ	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
70-75	70-75	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ativan	ativan	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Arrhythmias	Arrhythmia	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
noctural	noctural	JJ	I-NP	O
few	few	JJ	I-NP	O
beat	beat	JJ	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
significant	significant	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Rhabdo	Rhabdo	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
polymyositis	polymyositis	NN	I-NP	O
causing	cause	VBG	B-VP	O
muscle	muscle	NN	B-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
CK	CK	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
contribution	contribution	NN	I-NP	O
from	from	IN	B-PP	O
cocaine	cocaine	NN	B-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
far	far	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
work	work	NN	I-NP	O
up	up	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Preliminary	Preliminary	JJ	B-NP	O
biopx	biopx	NN	I-NP	O
sy	sy	NN	I-NP	O
shows	show	VBZ	B-VP	O
muscle	muscle	NN	B-NP	O
necrosis	necrosis	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
features	feature	NNS	B-NP	O
reminiscent	reminiscent	JJ	B-ADJP	O
of	of	IN	B-PP	O
dermatomyositis	dermatomyositis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
solumedrol	solumedrol	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	O
solumedrol	solumedrol	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
dropped	drop	VBD	B-VP	O
from	from	IN	B-PP	O
15	15	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
hovered	hover	VBN	B-VP	O
around	around	IN	B-PP	O
that	that	DT	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Rheumatology	Rheumatology	NNP	B-NP	O
Consult	Consult	NNP	I-NP	O
Fellow	Fellow	NNP	I-NP	O
Gavin	Gavin	NNP	I-NP	O
Nordman	Nordman	NNP	I-NP	O
felt	feel	VBD	B-VP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
under	under	IN	B-PP	O
treatment	treatment	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
true	true	JJ	I-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
recovery/impairment	recovery/impairment	NN	B-NP	O
will	will	MD	B-VP	O
only	only	RB	I-VP	O
be	be	VB	I-VP	O
known	know	VBN	I-VP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-PP	O
months	month	NNS	B-NP	O
.	.	.	O	O

diagnosis	diagnosis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Cr	Cr	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
at	at	IN	B-PP	O
1.3-1	1.3-1	CD	B-NP	O
.5	.5	CD	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
both	both	CC	O	O
renal	renal	JJ	B-NP	O
damage	damage	NN	I-NP	O
from	from	IN	B-PP	O
myoglobinuria	myoglobinuria	NN	B-NP	O
and	and	CC	B-PP	O
possibly	possibly	RB	B-ADVP	O
from	from	IN	B-PP	O
over-diureses	over-diures	NNS	B-NP	O
and	and	CC	O	O
pre-renal	pre-renal	JJ	B-NP	O
phsyiology	phsyiology	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
excellent	excellent	VB	I-VP	O
symptomatic	symptomatic	JJ	B-NP	O
response	response	NN	I-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
slow	slow	JJ	B-NP	O
tapering	tapering	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
in	in	IN	B-PP	O
attempt	attempt	NN	B-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
maximizing	maximize	VBG	B-VP	O
symptomatic	symptomatic	JJ	B-NP	O
resopnse	resopnse	NN	I-NP	O
and	and	CC	O	O
minimizing	minimize	VBG	B-VP	O
prerenal	prerenal	JJ	B-NP	O
physiology	physiology	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Mr	Mr	NNP	B-NP	O
Water	Water	NNP	I-NP	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
looking	look	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
anatomy	anatomy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vessels	vessel	NNS	I-NP	O
supplying	supply	VBG	B-VP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
diminished	diminish	VBN	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
do	do	VBP	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
condition	condition	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
your	your	PRP$	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
attacks	attack	NNS	I-NP	O
and	and	CC	I-NP	O
breaks	break	NNS	I-NP	O
down	down	IN	B-PP	O
your	your	PRP$	B-NP	O
muscle	muscle	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
you	you	PRP	B-NP	O
know	know	VBP	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
process	process	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
long	long	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
medication	medication	NN	B-NP	O
for	for	IN	B-PP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
four	four	CD	I-NP	O
to	to	TO	I-NP	O
eight	eight	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Zoelle	Zoelle	NNP	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
coordinate	coordinate	VB	I-VP	O
your	your	PRP$	B-NP	O
medication	medication	NN	I-NP	O
and	and	CC	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
disease	disease	NN	B-NP	O
afflicting	afflict	VBG	B-VP	O
the	the	DT	B-NP	O
valves	valve	NNS	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
a	a	DT	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Kissi	Kissi	NNP	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
new	new	JJ	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Holverson	Holverson	NNP	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
attend	attend	VBP	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
appointments	appointment	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
be	be	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

Lastly	Lastly	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
emphasized	emphasize	VBN	I-VP	O
enough	enough	RB	B-ADVP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
health	health	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
care	care	NN	I-NP	O
you	you	PRP	B-NP	O
take	take	VBP	B-VP	O
of	of	IN	B-PP	O
yourself	yourself	PRP	B-NP	O
,	,	,	O	O
making	make	VBG	B-VP	O
sure	sure	JJ	B-ADJP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
stop	stop	VB	B-VP	O
drinking	drink	VBG	I-VP	O
alcohol	alcohol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
stop	stop	VB	B-VP	O
taking	take	VBG	I-VP	O
any	any	DT	B-NP	O
illicit	illicit	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
for	for	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
black	black	JJ	B-NP	O
or	or	CC	I-NP	O
bloody	bloody	JJ	I-NP	O
stools	stool	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Myositis	Myositis	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
CK	CK	NN	B-NP	B-protein
,	,	,	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
additional	additional	JJ	B-NP	O
agent	agent	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
term	term	NN	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
,	,	,	O	O
response	response	NN	B-NP	O
may	may	MD	B-VP	O
take	take	VB	I-VP	O
weeks	week	NNS	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
NOT	NOT	NN	B-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
PND	PND	NN	B-NP	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
position	position	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tapered	taper	VBN	I-VP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
attempt	attempt	NN	B-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
proper	proper	JJ	I-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
relief	relief	NN	I-NP	O
while	while	IN	B-SBAR	O
not	not	RB	O	O
making	make	VBG	B-VP	O
him	him	PRP	B-NP	O
pre-renal	pre-renal	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WADDING	WADDING	NNP	B-NP	O
,	,	,	O	O
KIETH	KIETH	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AV66	AV66	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/17/06	5/17/06	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
07	07	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

